| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.35 | 1e-07 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.3 | 2e-06 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.22 | 0.0005 |